Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
BMC Cancer|August 23, 2023
Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression ≥ 50Wei Chen, Jiayi Chen, Lin Zhang, et al.
Journal of Inflammation Research|April 25, 2023
Immune-Related Colitis Induced by Camrelizumab: A Case ReportSheng Cheng, Yun Yang, Junxian Yu, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 17, 2017
Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future PerspectivesFang Geng, Zheng Wang, Hang Yin, et al.
Molecules (Basel, Switzerland)|October 15, 2016
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?Zhe Li, Qin Li, Jun Wu, et al.
British Journal of Hospital Medicine (London, England : 2005)|March 26, 2025
Predictive Value of Dietary Inflammatory Index for Recurrence of Plaque Psoriasis-A Retrospective StudyZheng Gu, Xiaoyan Zhang
Environmental Toxicology and Pharmacology|May 3, 2016
Inhibitory effects and mechanism of 25-OH-PPD on glomerular mesangial cell proliferation induced by high glucoseJunxian Yu, Chunna Liu, Zhe Li, et al.
Asia-Pacific Journal of Clinical Oncology|May 12, 2023
Efficacy and adverse events of immune checkpoint inhibitors in esophageal cancer patients: Challenges and perspectives for immunotherapyYingjie Ma, Junxian Yu, Xiaoting Ma, et al.
Plos One|April 20, 2016
Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot StudyAiping Wen, Zhe Li, Junxian Yu, et al.
Oncotargets and Therapy|May 23, 2018
Traditional Chinese medicine <i>Astragalus</i> polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosisJun Wu, Jing Wang, Qiang Su, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 27, 2017
Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC-MS/MS and the study of its pharmacokinetics and bioavailabilityFang Geng, Hang Yin, Zhe Li, et al.
Pageof 17